News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,022 Results
Type
Article (41234)
Company Profile (259)
Press Release (672528)
Multimedia
Podcasts (61)
Webinars (15)
Section
Business (206830)
Career Advice (2024)
Deals (35859)
Drug Delivery (95)
Drug Development (81388)
Employer Resources (172)
FDA (16448)
Job Trends (15014)
News (349108)
Policy (32926)
Tag
Academia (2599)
Accelerated approval (10)
Adcomms (22)
Allergies (96)
Alliances (50483)
ALS (109)
Alzheimer's disease (1465)
Antibody-drug conjugate (ADC) (152)
Approvals (16444)
Artificial intelligence (325)
Autoimmune disease (29)
Automation (19)
Bankruptcy (365)
Best Places to Work (11703)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (176)
Bladder cancer (93)
Brain cancer (34)
Breast cancer (368)
Cancer (2896)
Cardiovascular disease (213)
Career advice (1695)
Career pathing (30)
CAR-T (186)
CDC (30)
Cell therapy (501)
Cervical cancer (23)
Clinical research (67029)
Collaboration (1023)
Company closure (3)
Compensation (690)
Complete response letters (23)
COVID-19 (2650)
CRISPR (58)
C-suite (334)
Cystic fibrosis (114)
Data (3021)
Decentralized trials (2)
Denatured (20)
Depression (63)
Diabetes (347)
Diagnostics (6820)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (131)
Earnings (88267)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (115033)
Executive appointments (855)
FDA (18122)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (941)
Gene editing (132)
Generative AI (27)
Gene therapy (376)
GLP-1 (784)
Government (4548)
Grass and pollen (4)
Guidances (182)
Healthcare (19038)
HIV (41)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (147)
Immuno-oncology (10)
Indications (39)
Infectious disease (2824)
Inflammatory bowel disease (150)
Inflation Reduction Act (10)
Influenza (63)
Intellectual property (120)
Interviews (315)
IPO (16748)
IRA (45)
Job creations (3698)
Job search strategy (1437)
Kidney cancer (13)
Labor market (53)
Layoffs (497)
Leadership (19)
Legal (7981)
Liver cancer (81)
Longevity (11)
Lung cancer (404)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (392)
MASH (91)
Medical device (13615)
Medtech (13620)
Mergers & acquisitions (19835)
Metabolic disorders (852)
Multiple sclerosis (98)
NASH (16)
Neurodegenerative disease (116)
Neuropsychiatric disorders (32)
Neuroscience (2149)
NextGen: Class of 2025 (6562)
Non-profit (4544)
Now hiring (48)
Obesity (429)
Opinion (219)
Ovarian cancer (101)
Pain (107)
Pancreatic cancer (122)
Parkinson's disease (187)
Partnered (22)
Patents (302)
Patient recruitment (168)
Peanut (51)
People (58373)
Pharmaceutical (64)
Pharmacy benefit managers (21)
Phase I (20881)
Phase II (29533)
Phase III (21967)
Pipeline (1648)
Policy (202)
Postmarket research (2567)
Preclinical (8904)
Press Release (66)
Prostate cancer (143)
Psychedelics (38)
Radiopharmaceuticals (261)
Rare diseases (461)
Real estate (6010)
Recruiting (66)
Regulatory (22890)
Reports (50)
Research institute (2367)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (87)
Series A (158)
Series B (109)
Service/supplier (12)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (33)
Startups (3669)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (58)
The Weekly (39)
Vaccines (780)
Venture capital (55)
Weight loss (257)
Women's health (47)
Worklife (16)
Date
Today (76)
Last 7 days (349)
Last 30 days (1853)
Last 365 days (31410)
2025 (17028)
2024 (35519)
2023 (40432)
2022 (51549)
2021 (56105)
2020 (54582)
2019 (46972)
2018 (35404)
2017 (32524)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (736)
Alabama (61)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (38997)
Australia (6382)
California (7502)
Canada (2371)
China (674)
Colorado (321)
Connecticut (322)
Delaware (192)
Europe (84463)
Florida (1125)
Georgia (255)
Hawaii (1)
Idaho (59)
Illinois (646)
India (27)
Indiana (363)
Iowa (18)
Japan (231)
Kansas (110)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1032)
Massachusetts (5565)
Michigan (246)
Minnesota (460)
Mississippi (3)
Missouri (92)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (69)
New Jersey (2089)
New Mexico (30)
New York (2103)
North Carolina (1122)
North Dakota (9)
Northern California (3290)
Ohio (239)
Oklahoma (16)
Oregon (34)
Pennsylvania (1616)
Puerto Rico (17)
Rhode Island (36)
South America (1116)
South Carolina (34)
South Dakota (1)
Southern California (2820)
Tennessee (126)
Texas (1137)
United States (27845)
Utah (223)
Virginia (187)
Washington D.C. (72)
Washington State (649)
West Virginia (4)
Wisconsin (77)
714,022 Results for "amydis diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025
July 16, 2025
·
2 min read
Press Releases
Amydis to Present First Ocular Tracer Designed to Detect Transthyretin Amyloidosis (ATTR) at AAOOP Conference
October 10, 2024
·
3 min read
Press Releases
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 17, 2025
·
8 min read
Drug Development
Amydis Launches Phase 2 Glaucoma Clinical Program Using Novel Retinal Tracer to Detect Amyloid Beta
Amydis Inc. announced it has launched a Phase 2 clinical program for its novel retinal tracer, AMDX-2011P, to detect amyloid-beta in glaucoma patients.
November 2, 2023
·
3 min read
Press Releases
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
May 15, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
May 9, 2025
·
9 min read
Press Releases
Zomedica’s Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics
June 19, 2025
·
6 min read
Press Releases
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
May 8, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
April 29, 2025
·
1 min read
Biotech Beach
Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Grant Award to Map Heterogeneity of Alzheimer’s Diseases in Human Clinical Trial Using Novel Retinal Tracer
Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers to enable imaging of disease biomarkers in the eye, announced that it has received a two-year Commercialization Readiness Pilot Program grant award of $3.4 million from The National Institutes of Health.
November 14, 2023
·
3 min read
1 of 71,403
Next
